Why AbbVie Could Join the M&A Mania Soon
The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash.
Source: BioSpace
The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash.
Source: BioSpace